Related Experiment Video
Updated: Jun 25, 2026
04:50
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
Cell death in rheumatoid arthritis.
Adelheid Korb1, Hermann Pavenstädt, Thomas Pap
1Department of Internal Medicine, University Hospital Muenster, Munster, Germany.
Apoptosis : an International Journal on Programmed Cell Death
|February 10, 2009
Summary
Rheumatoid arthritis (RA) involves altered apoptosis in synovial cells, leading to joint destruction. Understanding these aberrant apoptotic mechanisms in RA offers potential therapeutic targets.
Area of Science:
- Immunology
- Cell Biology
- Rheumatology
Background:
- Apoptosis is crucial for tissue homeostasis, but is altered in rheumatoid arthritis (RA).
- In RA, synovial cells exhibit aberrant apoptosis, contributing to synovial hyperplasia and joint destruction.
- Fibroblast-like cells in RA become aggressive and invasive due to molecular changes.
Purpose of the Study:
- To review recent advancements in understanding aberrant apoptosis in the RA synovial membrane.
- To explore the mechanisms preventing apoptosis in RA synovial cells.
- To identify potential therapeutic interventions targeting apoptosis in RA pathogenesis.
Main Methods:
- Review of existing literature on apoptosis and rheumatoid arthritis.
- Analysis of molecular pathways involved in synovial cell apoptosis in RA.
- Examination of changes in mitochondrial pathways and death receptor modulators.
Main Results:
- Aberrant apoptosis in RA synovial cells promotes tissue destruction.
- Mechanisms preventing apoptosis include mitochondrial pathway alterations and modified expression of NF-kappaB.
- Fibroblast-like synoviocytes play a key role in RA-mediated joint damage.
Conclusions:
- Dysregulated apoptosis is a key feature of RA pathogenesis.
- Targeting aberrant apoptosis pathways presents a promising therapeutic strategy for RA.
- Further research into these mechanisms could lead to novel treatments for rheumatoid arthritis.
Related Concept Videos
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:30Overview of Cell Death
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
01:17Phagocytosis of Apoptotic Cells
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Normal cells contain receptors that prevent them from being recognized by phagocytes.